Capricor Therapeutics, Inc. (CAPR) vs Senseonics Holdings, Inc. (SENS)

A side-by-side comparison of Capricor Therapeutics, Inc. and Senseonics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CAPR vs SENS

growth of $100 · dividends reinvested · last 10y
CAPR -75.8% (-13.2%/yr)SENS -86.3% (-18.0%/yr)CAPR compounded faster over this window
050100Start $10020182020202220242026$24$14
CAPR SENS

CAPR vs SENS: by the numbers

  • •CAPR is the larger company ($441M vs $419M market cap).
  • •Both run net losses; CAPR's is the smaller (0.00% vs -225.34% net margin).

Metrics side by side

Valuation

MetricCAPRSENS
P/S ratioN/A8.64
P/B ratio1.794.64
EV / EBITDA0.44N/A

Profitability

MetricCAPRSENS
Gross margin0.00%44.71%
Operating margin0.00%-193.83%
Net margin0.00%-225.34%
ROE-52.56%-121.12%
ROIC-40.25%-71.22%

Growth (annualized)

MetricCAPRSENS
Revenue CAGR (5Y)N/A35.10%
Total return CAGR (5Y)15.17%-30.89%

Frequently asked

How have CAPR and SENS total returns compared?
Over the past 10 years, CAPR delivered -13.84% and SENS delivered -18.02% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.